If the disease industry would have the choice between, on the one hand, very expensive drugs against cancer that it has patented and that are so ineffective that many patients experience relapse within 2 to 3 years or get chronically ill and dependent on other drugs it produces and, on the other hand, cheap effective drugs, which cannot be patented, which one of the two do you expect Big Pharma would promote?